Investor News Updates: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Investor News Updates.

Press releases published on June 14, 2026

3 hours ago

Results Digital Scales Roofing Company from 3 Crews to 18, Gain Multi-Million Profit

Indeterminate EIN Presswire

9 hours ago

Miami Mortgage Broker Philip Bennett Explains How Foreign Nationals Can Finance Florida Real Estate Without U.S. Credit

Indeterminate EIN Presswire

9 hours ago

Miles Alexander III Launches ‘Mr. Miles World of Dreams’ Children’s Book Series to Inspire Young Readers

Indeterminate EIN Presswire

9 hours ago

Z-Text Bug Bounty Goes Live: 7 ZEC On-Chain to Anyone Who Breaks It

Indeterminate EIN Presswire

3 hours ago

ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WGS

Indeterminate GlobeNewswire

3 hours ago

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

3 hours ago

Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

3 hours ago

Bronstein, Gewirtz & Grossman LLC Urges POET Technologies Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

3 hours ago

Bronstein, Gewirtz & Grossman LLC Urges Lucid Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

3 hours ago

Bronstein, Gewirtz & Grossman LLC Urges Verra Mobility Corporation Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

3 hours ago

Bronstein, Gewirtz & Grossman LLC Urges Zillow Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Indeterminate GlobeNewswire

5 hours ago

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting

Indeterminate GlobeNewswire

5 hours ago

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

Indeterminate GlobeNewswire

5 hours ago

Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026

Indeterminate GlobeNewswire

6 hours ago

Bitcoin Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement

Indeterminate GlobeNewswire

Jun. 14, 2026

RISE OF CONCIERGE SERVICES TRANSFORMS LUXURY LIVING IN QUEENSLAND, AUSTRALIA

Indeterminate EIN Presswire

7 hours ago

Ruvi AI (RUVI) Announces Phase 3 Has Reached 90% Sellout as Investors Race to Secure Remaining Tokens at $0.02

Indeterminate GlobeNewswire

8 hours ago

MUSSO E80 Muse Sees Strong U.S. Sales Following European Breakout and MUSE Design Award Win

Indeterminate GlobeNewswire

8 hours ago

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

10 hours ago

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting

Indeterminate GlobeNewswire